Joint Stock Company “Grindeks” is an API and finished-dose manufacturer based in Latvia. It holds 2 active US drug master files across a filed portfolio of 3 molecules. Its filings concentrate with FAMHP (BE), DAV (Vietnam) and JFDA (JO). Its GMP standing is certified by NCELS (KZ).
| Site | FDA FEI |
|---|---|
| Riga, United Arab Emirates | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Oxytocin | SFDA (Saudi Arabia), US FDA | 3 |
| Droperidol | SFDA (Saudi Arabia), US FDA | 2 |
| Dexmedetomidine | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| FAMHP (BE) | 15 | None |
| DAV (Vietnam) | 7 | None |
| JFDA (JO) | 4 | None |
| COFEPRIS (MX) | 1 | None |
| NCELS (KZ) | None | 1 |
Choose your molecules and target markets. Joint Stock Company “Grindeks” comes back tiered against every other supplier able to file there.
Start for free